Recently, Beijing Rosenbot Technology Co., Ltd. announced the completion of the B-round financing of over 100 million yuan. This round of financing was led by Beijing Zhongguancun Science City and Shenzhen Venture Capital, followed by Qingkong Merchants Fund and Shengjing Capital. Life Capital acted as exclusive financial advisor.This round of financing will be mainly used to accelerate surgeryrobotNew product development, clinical registration, production expansion and global marketing.
It is understood that Rosenbot was established in 2017 and is the product of the combination of medicine and engineering between Beihang University and Beijing Jishuitan Hospital.medical robotCutting-edge technology original innovation. The company is committed to creating a new generation of intelligent orthopedic surgical robot system with fracture reduction function, and is the first in the world to realize advanced technologies such as intraoperative real-time 3D navigation, assisted fracture reduction operation, and automatic surgical planning, and realizes from closed fracture reduction to minimally invasive fixation Intelligent surgical operation of the whole surgical process.
Closed reduction surgery for pelvic fractures faces two major problems: the difficulty of fully displaying the three-dimensional structure of the pelvis through intraoperative fluoroscopy images, and the need for precise position and posture adjustment under high loads in closed reduction. In response to this clinical demand, Rosenbert has developed a new generation of intelligent orthopedic surgery robot system with fracture reduction function, including real-time three-dimensional intraoperative navigation of fractures, computer-aided automatic planning, and robot autonomous reset operations. The hard parts are done by Robots.”
Rosenbert founder Wang Yu said: “We hope to useDigitizingMeans ‘replicating’ the rich experience of clinical experts to achieve personalized surgical planning. Relying on the research and development path of strong medical-Industrial integration, Rosenbert aims to create a bottom-level general software and hardware platform with core competitiveness. In the future, surgical robots will be a platform-based development path. Rosenbert will build a product innovation system driven by clinical needs , supporting us to cover more clinical needs in the future.The rapid development of Robotic technology is changing the concept and model of the medical field. As an indispensable tool for minimally invasive surgery, Robotic systems have the potential to reduce socialthe medicalTotal cost, and the potential to improve access to medical re